🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Kilitch Drugs India Ltd (KIDI)

BSE
Currency in INR
324.20
-3.05(-0.93%)
Closed
KIDI Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
322.00330.95
52 wk Range
298.45469.85
Key Statistics
Edit
Bid/Ask
316.00 / 337.00
Prev. Close
327.25
Open
328.55
Day's Range
322-330.95
52 wk Range
298.45-469.85
Volume
1.01K
Average Volume (3m)
1.47K
1-Year Change
-6.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KIDI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
180.00
Downside
-44.31%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt
Show more

Kilitch Drugs India Ltd Company Profile

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-inflammatory, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, antifungals, corticosteroids, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, soft gelatin capsules, dry syrup, gripe water, and oral gel, powder, and liquid in the cardiovascular and anti-diabetics areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, and ROIVIT; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, creams, lotions, liquids, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.

Employees
168
Market
India

Compare KIDI to Peers and Sector

Metrics to compare
KIDI
Peers
Sector
Relationship
P/E Ratio
32.3x24.6x−0.6x
PEG Ratio
2.020.180.00
Price/Book
2.8x2.3x2.6x
Price / LTM Sales
3.4x2.7x3.2x
Upside (Analyst Target)
-4.2%40.6%
Fair Value Upside
Unlock−17.6%7.1%Unlock

FAQ

What Is the Kilitch Drugs India Ltd (KIDI) Stock Price Today?

The Kilitch Drugs India Ltd stock price today is 324.20.

What Stock Exchange Does Kilitch Drugs India Ltd Trade On?

Kilitch Drugs India Ltd is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Kilitch Drugs India Ltd?

The stock symbol for Kilitch Drugs India Ltd is "KIDI."

What Is the Kilitch Drugs India Ltd Market Cap?

As of today, Kilitch Drugs India Ltd market cap is 5.18B.

What is Kilitch Drugs India Ltd Earnings Per Share?

The Kilitch Drugs India Ltd EPS is 10.29.

What Is the Next Kilitch Drugs India Ltd Earnings Date?

Kilitch Drugs India Ltd will release its next earnings report on 17 Feb 2025.

From a Technical Analysis Perspective, Is KIDI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.